XML 34 R26.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

Fair Value Measurements | 3 Months Ended
--- | ---
Jun. 30, 2024
Fair Value Disclosures [Abstract] |
Fair Value Measurements | 15. Fair Value Measurements Certain assets and liabilities are recorded at fair value on the consolidated balance sheets and are measured and classified based upon a three-tiered approach to valuation. Financial assets and liabilities are recorded at fair value and are classified and disclosed in one of the following three categories: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2 – Quoted prices for identical or similar financial instruments in markets that are not considered to be active, or similar financial instruments for which all significant inputs are observable, either directly or indirectly, or inputs other than quoted prices that are observable, or inputs that are derived principally from or corroborated by observable market data through correlation or other means; and Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and are unobservable. These reflect management’s assumptions about the assumptions a market participant would use in pricing the asset or liability. A financial instrument’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Fair values of investments available-for-sale are based on quoted market prices, dealer quotes or discounted cash flows. Fair values of derivatives are based on using pricing valuation models which include broker quotes. The following tables represent the financial assets and liabilities on the consolidated balance sheets as of June 30, 2024 and March 31, 2024, that are measured at fair value on a recurring basis and the level within the fair value hierarchy.
As of June 30, 2024 |  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
|  | (Unaudited) |
Assets |  | (In thousands) |
Fixed maturities - available for sale |  | $ | 2,395,890 |  |  | $ | — |  |  | $ | 2,395,832 |  |  | $ | 58 |
Preferred stock |  |  | 22,067 |  |  |  | 22,067 |  |  |  | — |  |  |  | — |
Common stock |  |  | 51,999 |  |  |  | 51,999 |  |  |  | — |  |  |  | — |
Derivatives |  |  | 17,190 |  |  |  | 8,804 |  |  |  | 8,386 |  |  |  | — |
Total |  | $ | 2,487,146 |  |  | $ | 82,870 |  |  | $ | 2,404,218 |  |  | $ | 58 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |
Embedded derivatives |  | $ | 9,880 |  |  | $ | — |  |  | $ | — |  |  | $ | 9,880 |
Liabilities from investment contracts |  |  | 2,295,851 |  |  |  | — |  |  |  | — |  |  |  | 2,295,851 |
Market risk benefits |  |  | 13,447 |  |  |  | — |  |  |  | — |  |  |  | 13,447 |
Total |  | $ | 2,319,178 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,319,178 |
As of March 31, 2024 |  | Total |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |
|  | (In thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |
Fixed maturities - available for sale |  | $ | 2,442,504 |  |  | $ | — |  |  | $ | 2,442,446 |  |  | $ | 58 |
Preferred stock |  |  | 21,260 |  |  |  | 21,260 |  |  |  | — |  |  |  | — |
Common stock |  |  | 45,014 |  |  |  | 45,014 |  |  |  | — |  |  |  | — |
Derivatives |  |  | 18,930 |  |  |  | 10,538 |  |  |  | 8,392 |  |  |  | — |
Total |  | $ | 2,527,708 |  |  | $ | 76,812 |  |  | $ | 2,450,838 |  |  | $ | 58 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |
Embedded derivatives |  | $ | 9,300 |  |  | $ | — |  |  | $ | — |  |  | $ | 9,300 |
Liabilities from investment contracts |  |  | 2,290,096 |  |  |  | — |  |  |  | — |  |  |  | 2,290,096 |
Market risk benefits |  |  | 13,400 |  |  |  | — |  |  |  | — |  |  |  | 13,400 |
Total |  | $ | 2,312,796 |  |  | $ | — |  |  | $ | — |  |  | $ | 2,312,796 |
We estimate the fair value for financial instruments not carried at fair value using the same methods and assumptions as those we carry at fair value. The financial instruments presented below are reported at carrying value on the consolidated balance sheets. Cash equivalents were $870.5 million and $1,173.6 million as of June 30, 2024 and March 31, 2024, respectively. Fair values of cash equivalents approximate carrying value due to the short period of time to maturity. Fair values of mortgage loans and notes on real estate are based on quoted market prices, dealer quotes or discounted cash flows. Fair values of trade receivables approximate their recorded value. Our financial instruments that are exposed to concentrations of credit risk consist primarily of temporary cash investments, trade receivables, and notes receivable. Limited credit risk exists on trade receivables due to the diversity of our customer base and their dispersion across broad geographic markets. We place our temporary cash investments with financial institutions and limit the amount of credit exposure to any one financial institution. We have mortgage loans, which potentially expose us to credit risk. The portfolio of loans is principally collateralized by self-storage facilities and commercial properties. We have not experienced any material losses related to the loans from individual or groups of loans in any particular industry or geographic area. The estimated fair values were determined using the discounted cash flow method and using interest rates currently offered for similar loans to borrowers with similar credit ratings. Other investments are substantially current or bear reasonable interest rates. As a result, the carrying values of these financial instruments approximate fair value. The following represents our financial instruments not carried at fair value on the consolidated balance sheets and corresponding placement in the fair value hierarchy.
|  | Fair Value Hierarchy |
|  | Carrying |  |  |  |  |  |  |  |  |  |  |  | Total |
As of June 30, 2024 |  | Value |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Fair Value |
|  | (Unaudited) |
Assets |  | (In thousands) |
Trade receivables, net |  | $ | 215,735 |  |  | $ | — |  |  | $ | — |  |  | $ | 215,735 |  |  | $ | 215,735 |
Mortgage loans, net |  |  | 617,230 |  |  |  | — |  |  |  | — |  |  |  | 589,880 |  |  |  | 589,880 |
Other investments |  |  | 12,389 |  |  |  | — |  |  |  | — |  |  |  | 12,389 |  |  |  | 12,389 |
Total |  | $ | 845,354 |  |  | $ | — |  |  | $ | — |  |  | $ | 818,004 |  |  | $ | 818,004 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Notes, loans and finance leases payable |  | $ | 6,311,676 |  |  | $ | — |  |  | $ | 5,888,119 |  |  | $ | — |  |  | $ | 5,888,119 |
Total |  | $ | 6,311,676 |  |  | $ | — |  |  | $ | 5,888,119 |  |  | $ | — |  |  | $ | 5,888,119 |
|  | Fair Value Hierarchy |
|  | Carrying |  |  |  |  |  |  |  |  |  |  |  | Total |
As of March 31, 2024 |  | Value |  |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Fair Value |
|  | (In thousands) |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Trade receivables, net |  | $ | 177,602 |  |  | $ | — |  |  | $ | — |  |  | $ | 177,602 |  |  | $ | 177,602 |
Mortgage loans, net |  |  | 604,481 |  |  |  | — |  |  |  | — |  |  |  | 579,767 |  |  |  | 579,767 |
Other investments |  |  | 18,917 |  |  |  | — |  |  |  | — |  |  |  | 18,917 |  |  |  | 18,917 |
Total |  | $ | 801,000 |  |  | $ | — |  |  | $ | — |  |  | $ | 776,286 |  |  | $ | 776,286 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Notes, loans and finance leases payable |  |  | 6,304,038 |  |  |  | — |  |  |  | 5,850,346 |  |  |  | — |  |  |  | 5,850,346 |
Total |  | $ | 6,304,038 |  |  | $ | — |  |  | $ | 5,850,346 |  |  | $ | — |  |  | $ | 5,850,346 |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 107 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2E -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6A -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 940 -SubTopic 820 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1 + Details
Name: | us-gaap_FairValueDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration